$326 million, Kingswood Capital purchases Corbion's emulsifier business

  • 31-January-2024

The deal to buy the emulsifier division of industry titan Corbion has been finalized by renowned private equity firm Kingswood Capital Management. Kingswood Capital, whose investments span a variety of industries including consumer, energy, retail, and technology, made the strategic decision to acquire the business for an estimated $326 million.

Acquisition Information

The acquisition includes about 175 workers and two US-based manufacturing facilities. Kingswood Capital's significant investment is consistent with their prior food-related ventures, which include holdings in Save Mart, a strong retail chain, and G Fuel, a thriving energy drink manufacturer.

Prospective Objectives and Perspectives

Kingswood managing partner Alex Wolf expressed his optimism for the emulsifiers industry's future. He emphasized upholding the company's reputation for providing high-quality service while expanding on its history. He stressed that the ultimate objective is to create the largest standalone pure-play emulsifiers company in North America.

Corbion's Point of View

For Corbion, the sale is a chance to sharpen its focus on its primary area of expertise, fermentation-based technologies. The significance of customer and employee welfare in the transaction was emphasized by Andy Muller, president of Corbion's sustainable food solutions division. He attested to the fact that the agreement is in line with the right partners and leadership to further accelerate business growth.

This acquisition represents Corbion's strategic growth as well as Kingswood Capital's commitment to narrowing their focus. It bears witness to the dynamic character of the business world, where change is not only unavoidable but frequently denotes advancement and development.

Related Post

5 recipes that reduce inflammation: anti-inflammat..

An essential component of your body's defense syst..

The Critical Role of the ENT Specialist in Head an..

In the dynamic field of oncology, the role of Ear,..